18 studies found for:    0815
Show Display Options
Rank Status Study
1 Completed Relapse Prevention With Varenicline
Conditions: Recurrence;   Smoking Cessation;   Substance-Related Disorders
Interventions: Drug: Varenicline;   Drug: Placebo
2 Completed
Has Results
Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery
Condition: Pancreatic Cancer
Interventions: Drug: Sorafenib;   Drug: Erlotinb
3 Completed Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
Conditions: Childhood Central Nervous System Choriocarcinoma;   Childhood Central Nervous System Embryonal Tumor;   Childhood Central Nervous System Germ Cell Tumor;   Childhood Central Nervous System Germinoma;   Childhood Central Nervous System Mixed Germ Cell Tumor;   Childhood Central Nervous System Teratoma;   Childhood Central Nervous System Yolk Sac Tumor;   Metastatic Childhood Soft Tissue Sarcoma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Central Nervous System Embryonal Tumor;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Childhood Visual Pathway Glioma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: pazopanib hydrochloride;   Other: pharmacological study
4 Completed Chronic Inflammatory Activation in Fat Tissue: an Atherogenic Factor in Stable Coronary Artery Disease
Conditions: Stable Coronary Artery Disease;   Obesity;   Impaired Glucose Tolerance
Interventions: Other: training;   Other: training + metformin;   Other: training + glitazon
5 Active, not recruiting Enhancement of Hand Motor Function After Cervical Spinal Cord Injury
Condition: Spinal Cord Injury
Interventions: Procedure: High frequency non-invasive repetitive transcranial magnetic stimulation;   Procedure: Sham rTMS over control brain area
6 Not yet recruiting Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia
Condition: Primacy Immune Thrombocytopenia
Intervention: Drug: Eltrombopag
7 Recruiting Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
8 Terminated Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma;   Pleural Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
9 Recruiting A Study of Ganetespib in Combination With Chemoradiation
Condition: Esophageal Cancer
Interventions: Drug: Ganetespib;   Drug: Carboplatin;   Drug: Paclitaxel;   Radiation: Radiotherapy
10 Terminated Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
Condition: Melanoma
Intervention:
11 Completed Lung Deposition of the BDP/Formoterol Combination Administered Via the NEXT DPI in Healthy, Asthmatic and COPD Patients
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma
Intervention: Drug: BDP/formoterol NEXT DPI
12 Completed A Key Link for Transmission Prevention
Condition: HIV
Interventions: Behavioral: Standard HIV prevention messages;   Behavioral: 5 counselor-delivered sessions;   Drug: ARVs with raltegravir and emtricitabine/tenofovir disoproxil fumarate
13 Completed Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
Condition: Gout
Interventions: Biological: Rilonacept;   Other: Placebo
14 Completed Hypopituitarism After Aneurismal Subarachnoid Hemorrhage
Conditions: Aneurismal Subarachnoid Hemorrhage;   Hypopituitarism;   Neuropsychological Deficits
Intervention:
15 Completed
Has Results
Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: tiotropium;   Drug: placebo
16 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2
17 Unknown  Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw
Condition: Blood Loss
Intervention: Device: CM 1500
18 Recruiting The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study
Condition: Fatigue
Intervention: Drug: Modafinil

Indicates status has not been verified in more than two years